A photoactivated chemiluminescence POCT immunoanalyzer platform requiring no refrigeration for storage or transport. Performs whole blood testing without additional consumables and delivers high sensitivity results.
Manufactured by
China
Xenta Biomedical Science Co., Ltd, founded in December 2021 and headquartered in Guangzhou Development District, is a national high-tech enterprise focused on the R&D, registration, and commercialization of in vitro diagnostic (IVD) reagents and devices. With fully paid-up capital of RMB 10 million, the company is led by a team of returnee PhDs with strong international research and industry experience. It is dedicated to developing innovative POCT technology platforms under the philosophy of "Faster, Better, and More Accessible". The company drives innovation through R&D centers in Guangzhou, Xiamen, and overseas. Using its proprietary dry light-excited chemiluminescence POCT platform, it has developed leading product series and managed major national research projects. The company has published over 20 SCI papers, holds 70 patents, has obtained more than 60 EU CE certifications, and 12 FDA approvals in the United States. Currently, several product lines are actively striving for NMPA certification. Its pipeline covers key areas including cardiovascular, inflammation, oncology, hormone, and infectious diseases, demonstrating end-to-end capabilities from R&D to global commercialization. The core team comprises graduates from top universities such as Texas A&M University, Xiamen University, Sanford-Burnham Medical Research Institute, and Sun Yat-sen University, possessing multidisciplinary expertise in biomedicine, engineering, and law. The co-founders have extensive experience from leading IVD companies, having previously guided teams to achieve annual revenues exceeding several hundred million yuan and secure over 200 product certifications worldwide. Since its establishment, Xenta Biomedical Science Co., Ltd has raised tens of millions in funding and obtained ISO 13485 certification, supporting its global expansion.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai STAC Biotechnology Co., Ltd.
China · 1 relevant product
Chongqing Isia Bio-Technology Co Ltd
China · 1 relevant product
Shenzhen Tiachen Medical Technology CO., Ltd
China · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
B&C Biological
China · 1 relevant product
Chengdu Illumaxbio Technology Co.,LTD
China · 2 relevant products
Render Biotech Co., Ltd.
China · 1 relevant product
Beijing Sinomedisite Bio-tech Co., Ltd
China · 1 relevant product
Jiangsu Zecen Biotechnology Co., Ltd
China · 1 relevant product
EBD BIOTECH
Brazil · 1 relevant product
5 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 16 closest product alternatives
Shanghai STAC Biotechnology Co., Ltd. · China
POCT dry fluorescence immunoassay test kits and immunoanalyzer for rapid point-of-care diagnostics. Designed for hematology and clinical chemistry applications with integrated reagent, calibrator, and control solutions. CE and ISO 13485 certified with compatibility across leading analyzer platforms.
Chongqing Isia Bio-Technology Co Ltd · China
A single channel fluorescent immunoanalyzer utilizing Quantum Dots immunofluorescence technology for point-of-care testing. Offers high-speed analysis at 120 tests per hour with ultra-high sensitivity and exceptional stability for in vitro diagnostics applications.
Shenzhen Tiachen Medical Technology CO., Ltd · China
A fully automatic chemiluminescence immunoassay analyzer system for clinical diagnostic testing. The device features compact design with volume less than 0.2 m³, coefficient of variation less than 5%, and can complete standard five-marker testing in approximately 14 minutes using liquid-phase chemiluminescence technology.
guangzhou biotron technolongy co.,ltd · China
Point-of-care testing platform based on immunochemical principles for rapid on-site diagnostic testing without laboratory infrastructure requirements.
B&C Biological · China
A POCT-series chemiluminescence immunoassay analyzer designed for point-of-care diagnostic testing. This instrument is part of B&C Biological's POCT product line for rapid immunodiagnostic applications in clinical settings.
Chengdu Illumaxbio Technology Co.,LTD · China
Portable chemiluminescence immunoassay analyzer (POCT CLIA) for point-of-care diagnostics. The Lumilite 8 system delivers core laboratory precision with compact design, enabling rapid immunoassay testing in clinical settings. Supports single-test and multiplex assay protocols for streamlined diagnostic workflows.
Render Biotech Co., Ltd. · China
An automated analyzer for point-of-care testing (POCT) that performs chemiluminescence immunoassays. The device is designed for immunological testing applications and is part of the company's in vitro diagnostic automation product portfolio.
Beijing Sinomedisite Bio-tech Co., Ltd · China
Fluorescence immunochromatography analyzer for rapid point-of-care testing (POCT) and clinical diagnostics. Detects biomarkers and analytes using fluorescence-based immunoassay technology for disease screening and monitoring. Integrates with chronic disease management systems for automated result processing and data management.
Jiangsu Zecen Biotechnology Co., Ltd · China
Point-of-care testing chemiluminescence system for rapid diagnostic testing. Designed for use in hospitals, disease control centers, and health examination centers.
EBD BIOTECH · Brazil
Portable fluorescence immunoassay system for rapid point-of-care diagnostic testing. Enables detection and quantification of biomarkers in clinical specimens through fluorescence-based immunoassay methodology. Designed for laboratory and clinical use with portable form factor for decentralized testing applications.
Chengdu Illumaxbio Technology Co.,LTD · China
Automatic fluorescence immunoassay system for point-of-care testing delivering core-laboratory precision results. The P16 X-POCT platform performs chemiluminescent immunoassay analysis with multiplex capability, enabling rapid clinical diagnostics in decentralized care settings. Ready-to-use test cartridges and integrated analyzer reduce turnaround time for infectious disease, cardiac, and immunology testing.
Snibe Co.,Ltd · China
Fully automated chemiluminescence immunoassay system for high-throughput in-vitro diagnostics. Offers up to 236 test parameters for quantitative and qualitative analysis across multiple disease states. Delivers accurate results with broad laboratory application capability.
4 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products